DBV Technologies Provides 2013 Year-End Summary And News Flow Guidance For 2014
BAGNEUX, France, Dec. 17, 2013 (GLOBE NEWSWIRE) -- DBV Technologies (Euronext: DBV - ISIN: FR0010417345), creator of Viaskin®, a new paradigm for the treatment of allergies, announced today a summary of corporate activities in 2013 and provided news flow guidance for 2014.
Help employers find you! Check out all the jobs and post your resume.